| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |